Covid-19 vaccines, tests and treatments spur healthcare M&A deals
Mergers & Acquisitions explores 5 ways the coronavirus is changing dealmaking, as pharmaceutical companies scramble to develop vaccines, diagnostic tools and treatments.
Mergers & Acquisitions explores 5 ways the coronavirus is changing dealmaking, as pharmaceutical companies scramble to develop vaccines, diagnostic tools and treatments.
